Bio-Techne
TECH
#1778
Rank
HK$89.58 B
Marketcap
HK$570.25
Share price
0.06%
Change (1 day)
26.69%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): HK$9.14

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is HK$9.17. In 2025 the company made an earnings per share (EPS) of HK$4.08 a decrease over its 2024 EPS that were of HK$7.84.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$9.14124.33%
2025HK$4.08-48%
2024HK$7.84-29.58%
2023HK$11.13-14.97%
2022HK$13.0924.16%
2021HK$10.5417.98%
2020HK$8.94-10.94%
2019HK$10.03101.57%
2018HK$4.98-16.99%
2017HK$6.0045.02%
2016HK$4.14-20.97%
2015HK$5.23-14.97%
2014HK$6.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
HK$148.86 1,523.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$28.22 207.69%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$68.43 646.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
HK$47.97 423.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
HK$15.56 69.64%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-HK$1.65-117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
HK$299.14 3,161.54%๐Ÿ‡บ๐Ÿ‡ธ USA